ity was 6% (none in our group), which occurred mostly in combination when renal transplantation and PVG replacement was performed simultaneously. Conclusion: Grafting of the renal artery to a PVG is feasible and yields good results, despite the technical difficulties involved.
Introduction
Characteristics of kidney transplant recipients have changed over the last decades. An increase in the number of patients with chronic kidney disease is partly due to demographic reasons [1, 2] . In addition, waiting times are increasing due to a decrease in organ donations. Aging of the population on organ waiting lists and longer periods of dialysis therapy are associated with an increase of atherosclerotic lesions in the recipients. Therefore, additional vascular procedures before or during transplantation are sometimes needed. The success of kidney transplantation depends to a large extent on the quality of vascular access and especially an uncompromised blood inflow. Surgical approaches to ensure appropriate blood supply include prosthetic vessel replacement as tactical or simultaneous procedure in preparation for renal transplantation. However, in the 1970s, the use of synthetic arterial grafts in transplant recipients was considered as risky because of a higher incidence of septicemia [3] . These concerns have created a cautious approach to the use of such grafts in transplant patients. The outcomes of this approach have not been systematically evaluated.
We report here the results of 4 out of 208 (2%) deceased donor kidney transplantations performed in our own transplant center during the last 4 years with prosthetic iliac vessel replacement because of aneurysm or occlusive arterial disease ( fig. 1 ) and those of 170 cases summarized in 18 reports published during the last 25 years, as identified by a Medline search.
Material and Methods
This study was approved by the local ethics committee of the University Hospital of Erlangen, Germany, and informed consent was obtained from every single patient treated and investigated in our department, which included permission to use data from chart review. The study was performed in accordance with the Helsinki Declaration.
Subjects
We reviewed 208 consecutive patients who received a deceased donor graft between January 2011 and December 2014. Transplantations were performed by an interdisciplinary team composed of members of the Departments for Vascular Surgery and Urology of the University of Erlangen-Nürnberg, Germany. The average recipient age was 52 ± 13.6 years; 67% of the recipients were male. We could identify 4 patients (2%) with prosthetic vessel replacement on transplantation site because of aneurysm or occlusive arterial disease (mean age 56 ± 2.9 years; all male). They were performed as tactical (in 3 cases) or as simultaneous (in 1 case) procedures. Patients without additional vascular procedures served as control group (n = 204/208).
All recipient and organ data were collected and retrospectively analyzed using a computer-based system. Follow-up data were also collected by our transplant program in cooperation with the Department of Nephrology of the University of Erlangen, Germany, and Eurotransplant, Leyden, The Netherlands. The patient demographic and clinical data were collected at the time of transplantation, during hospitalization until discharge by chart review. Every recipient had received pre-operative imaging (Doppler and duplex ultrasound and magnetic resonance angiography or computed tomographic angiography) to evaluate the degree of vascular disease at the access site. An intra-arterial angiogram with digital subtraction has been added when iliac artery stenosis were interventionally treatable or definitively diagnosed with non-invasive imaging.
We compared our findings with those reported in literature. Relevant publications were identified through search of the Medline database using the terms: 'aorto-iliac occlusive disease', 'aortoiliac surgery', 'renal/kidney transplantation', 'arterial reconstruction', 'vascular complications', 'prosthesis' and 'renal artery'. Eighteen publications could be identified between 1989 until 2015, mostly with small cohorts providing information on 170 patients in total with arterial anastomosis of a renal transplant on a prosthetic vessel (ARTPV) to our collective ( table 1 ) .
We excluded reports about implantations of alloplastic vascular prosthesis on recipient site after a renal transplantation and cases in which other material was used for vascular replacement (e.g., homografts). Hence, only information about prosthetic vascular replacement as a tactical (before) or simultaneous procedure was evaluated. Publications describing renal artery anastomosis outside the synthetic prosthesis and reports not providing information on the clinical status of the patients, graft survival or complications during/after kidney transplantation were excluded.
The references finally retained were chosen based on their relevance to topics addressed herein and to answer several questions that are important in clinical practice: demographic data of the transplanted population, imaging for transplant evaluation, tactical or simultaneous surgical procedures, complications, mortality, graft survival and therapeutic approach.
All patients transplanted at the University Hospital of Erlangen, Germany, received immunosuppression with a calcineurin inhibitor, such as cyclosporine or tacrolimus, antimetabolic agents and steroids. Organ procurement and transplantation were performed according to standard techniques [4] . All recipients were given prophylactic broad-spectrum parenteral antibiotics in the operating room at the time of transplant. Postoperative anti-coagulation therapy was not routinely performed and only prescribed when medically or surgically indicated. Patients with prosthetic vessel received prophylactic, weight adjusted heparin administration. The mean follow-up was 22 ± 14.6 months. None of the transplanted patients were lost to follow-up. The graft function was initially evaluated by urine production in the first 24 h after transplantation and by serum creatinine levels at defined time points. Doppler and duplex echo studies were employed to evaluate graft perfusion in all cases. 
Statistical Methods
Data are reported as mean ± SD. Wilcoxon rank-sum test was used to assess differences between groups. The data were analyzed using SPSS for Windows, version 21.0 (SPSS Inc., Chicago, Ill., USA).
Results
A summary of the characteristics of all kidney transplant patients treated at our center during the 4-year period is presented in table 2 .
ARTPV in Our Clinic and in Literature
The mean age of the 4 patients with ARTPV in our center was 56 ± 2.9 years (minimum 52, maximum 59 years; all male). The mean age of the 170 ARTPV patients reported in 18 published articles was 56 ± 5.5 years (minimum 44, maximum 64 years; mostly male) and thus very similar to our patients. While 3 of our 4 ARTPV patients received 'tactical' surgery with a prosthetic bypass for revascularization prior to transplantation, this approach was chosen in 58% of published cases (n = 98/170) and simultaneous revascularization with a prosthetic graft was performed in a lower proportion of 42% (n = 72/170). In the majority of the reported cases and in our cases, an aorto-bifemoral dacron prosthesis implantation was used and the graft renal artery was implanted in an end-to-side fashion to the synthetic vessel.
Infection as a complication associated with kidney transplantation was reported in 6 of 170 cases in literature (3.5%) whereas we could not observe such a problem in our 4 patients. Redo surgery was necessary in 15% of cases described in literature (n = 25 of 170; 15%), the most frequent reasons being hematoma (n = 9 of 170; 5%) and transplant nephrectomy due to transplant failure (n = 7 of 170; 4%). Among our cases, 1 patient required surgery to remove a hematoma at the transplant site.
Thirty-day mortality in the published cases was on average 6% (n = 10 of 170), and most deaths occurred when renal transplantations were performed simultaneously with ARTPV. The most frequently reported cause of death during the first 30 days was myocardial infarction (n = 6 of 10). No early deaths occurred in our patients.
Mean serum creatinine at the end of follow-up reported in 5 publications [5-9] was 1.44 mg/dl and comparable with our experience (1.56 mg/dl; n.s.).
Among published cases only one study provided information on resistance indices (RIs) assessed by Doppler/ duplex ultrasound and reprised these as normal, without providing values [8] . In our own cases, we could follow RIs throughout the second year of follow-up. Mean values increased from 0.57 immediately after transplantation to 0.72 after 6 months and 0.69 after the first and second year.
Five-year graft survival rate was reported in 12 studies and ranged from 17% [10] to 100% [11] . In our cases, graft survival was 100% during a mean follow-up of 23 ± 14.1 months.
Kidney Transplantations without the Need for a Prosthetic Vessel Replacement (NoARTPV)
Two hundred and four kidney transplant recipients without prosthetic vessel replacement served as control group (NoARTPV). Their mean age was 51 ± 16.1 years (minimum 5, maximum 77 years) and thus on average 4 years higher (p = 0.001). Infection of the surgical site or sepsis was not observed. A complication with the necessity for redo surgery occurred in 13 of 204 cases (6%). Indications are shown in table 3 . Serum creatinine at the end of follow-up was 1.54 ± 0.69 mg/dl and not significantly different compared to our 4 cases with ARTPV or ARTPV cases reported in the literature. RIs were 0.63 immediately after transplantation, increased to 0.70 after 6 months and 0.68 after 12 months. Compared to patients without ARTPV, the increase in RI tended to be slightly fig. 2 ), but at no time point was the RI significantly different between both groups.
Three-year graft survival rate was 91.2% and not significantly different from the graft survival rate of ARTPV cases reported in the literature (p = 0.692; n.s.).
Discussion
The main finding of this combined report of single-center experience and literature review is that kidney transplantation can be successfully performed in patients with severe aorto-iliac lesions by anastomosing the graft to a prosthetic aorto-iliac graft that is either implanted prior to (tactical) or during transplantation (simultaneous).
Sterioff et al. [12] showed already in 1974 that kidney transplantation was possible in patients with arterial prosthetic grafts. In 1979, Ahlmen et al. [13] reported the case of a 62-year-old man who benefited from a renal transplantation 12 years after an aorto-bi-iliac graft for aortic aneurysm. However, subsequent reports about grafting the renal artery to a vascular prosthesis during kidney transplantation have revealed conflicting results. In a multicenter Dutch study, discouraging outcomes were reported, with 23% graft loss and 15% perioperative mortality rates [10] . In a more recent study reporting a series of 11 patients in whom the 2 procedures were performed simultaneously, 2 grafts were lost because of bleeding from the anastomotic site and primary nonfunction resulting from prolonged warm ischemia [14] . Poor results were also observed in another study with 10% perioperative mortality due to myocardial infarction and loss of up to 23% of allografts implanted on a vascular prosthesis [7] . Other studies showed good results of kidney transplantation in association with alloplastic prosthesis replacement procedures [5, 6, 11, [15] [16] [17] [18] [19] [20] [21] [22] . Our own 162 experience in 4 cases is in line with these findings. Moreover, outcome data as well as complication rates were not different from cases in our own program where regular anastomosis was performed between endogenous vessels. Nevertheless careful evaluation and election of cases as well as planning of the procedure may be necessary to achieve such outcomes. For example, performing transplantation after insertion of an aortic prosthetic graft can pose technical problems caused by scaring. The recipient iliac vessels may undergo profound changes after the first operation and gaining control for a sufficiently long venous segment to anastomose the transplant vein may be difficult. These difficulties are likely the cause of an increased risk for hematoma formation, which requires redo surgery in 5% of cases. The disastrous effects of infection in and around synthetic arterial grafts have been well documented, but overall the infection rate in published reports during the last 25 years was only 3.5%. This may be due to routine antibiotic therapy during transplantation and careful handling of the urinary bladder before opening it for ureteral anastomosis. In our clinic, for example, we flush the bladder from the beginning of transplantation with diluted polyvinyl iodide in an attempt to minimize contamination of the operative sites during ureteral anastomosis. Moreover, current immunosuppressive regimes may be associated with a lower risk of over immunosuppression as compared strategies used several decades ago.
Given the increasing age of transplant candidates and their increasing waiting time, transplant management in the presence of severe atherosclerotic disease has increasing relevance. It is widely accepted that potential recipients and patients with transplants should have a comprehensive vascular evaluation as part of their follow-up examination on hemodialysis or after transplantation. While the findings reported in this study suggest that patients with severe aorto-iliac atherosclerosis do not necessarily have to be excluded from transplantation, it is important to recognize that the need for a prosthetic vessel replacement to create arterial access for the renal graft is an indicator for a generalized atherosclerotic burden. Peripheral arterial occlusive disease is considered as an indicator for coronary heart disease. In the publications summarized in this report, 30-day-mortality is dominated by myocardial infarction (60% of early deaths) and was reported mainly when prosthetic vessel replacement was combined simultaneously with kidney transplantation. This might suggest that elective reconstruction of stenotic vessels should better be undertaken prior to transplantation. Moreover, these findings also support the concept that patients with severe peripheral artery disease require a work-up for coronary artery disease.
We could show that renal function in renal grafts anastomosed on a prosthetic arterial vessel was not inferior when compared with regular renal transplantations. Our own experience in a small group of 4 cases also provided no evidence for hypoperfusion of kidneys anastomosed to a prosthetic graft. Centers should reconsider their acceptance criteria of recipients with prosthetic vessel replacement on implantation site like they should do for marginal donor kidneys [27] because of similar results compared with regular recipients and donors.
Conclusion
In summary, our findings illustrate that neither aortoiliac occlusive disease nor abdominal aortic aneurysms constitute absolute contraindications for renal transplantation. Staged (tactical) surgical repair of aorto-iliac lesions followed by renal transplantation is possible with acceptable risk despite the increased technical demand. This emphasizes the need for adequate skills in vascular surgery and close collaboration between the transplant team and vascular surgeons.
